ESSA Pharma EPIX Stock
7.76 USD
{{ price }}
-5.939391%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
343.29M USD
LOW - HIGH [24H]
7.75
-
8.49 USD
VOLUME [24H]
16.91K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.59 USD
ESSA Pharma Price Chart
ESSA Pharma EPIX Financial and Trading Overview
| ESSA Pharma stock price | 7.76 USD |
| Previous Close | 3.2 USD |
| Open | 3.15 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 3.01 - 3.28 USD |
| 52 Week Range | 1.4 - 5.16 USD |
| Volume | 50.72K USD |
| Avg. Volume | 62.31K USD |
| Market Cap | 143.3M USD |
| Beta (5Y Monthly) | 2.088028 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.4 USD |
EPIX Valuation Measures
| Enterprise Value | -15802849 USD |
| Trailing P/E | N/A |
| Forward P/E | -3.25 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.91652566 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
ESSA Pharma Stock Price History
| Beta (5Y Monthly) | 2.088028 |
| 52-Week Change | -23.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.16 USD |
| 52 Week Low | 1.4 USD |
| 50-Day Moving Average | 2.94 USD |
| 200-Day Moving Average | 2.83 USD |
EPIX Share Statistics
| Avg. Volume (3 month) | 62.31K USD |
| Avg. Daily Volume (10-Days) | 30.11K USD |
| Shares Outstanding | 44.09M |
| Float | 24.44M |
| Short Ratio | 3.46 |
| % Held by Insiders | 5.83% |
| % Held by Institutions | 75.72% |
| Shares Short | 146.89K |
| Short % of Float | 0.54% |
| Short % of Shares Outstanding | 0.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.90% |
| Return on Equity (ttm) | -17.28% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -28952848 USD |
| Diluted EPS (ttm) | -0.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 157.04M USD |
| Total Cash Per Share (mrq) | 3.56 USD |
| Total Debt (mrq) | 145.27K USD |
| Total Debt/Equity (mrq) | 0.09 USD |
| Current Ratio (mrq) | 73.658 |
| Book Value Per Share (mrq) | 3.546 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26468312 USD |
| Levered Free Cash Flow (ttm) | -15248561 USD |
Profile of ESSA Pharma
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 999 West Broadway |
| ZIP | V5Z 1K5 |
| Phone | N/A |
| Website | https://www.essapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. The company develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. It has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Q&A For ESSA Pharma Stock
What is a current EPIX stock price?
ESSA Pharma EPIX stock price today per share is 7.76 USD.
How to purchase ESSA Pharma stock?
You can buy EPIX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ESSA Pharma?
The stock symbol or ticker of ESSA Pharma is EPIX.
Which industry does the ESSA Pharma company belong to?
The ESSA Pharma industry is Biotechnology.
How many shares does ESSA Pharma have in circulation?
The max supply of ESSA Pharma shares is 44.24M.
What is ESSA Pharma Price to Earnings Ratio (PE Ratio)?
ESSA Pharma PE Ratio is now.
What was ESSA Pharma earnings per share over the trailing 12 months (TTM)?
ESSA Pharma EPS is -0.59 USD over the trailing 12 months.
Which sector does the ESSA Pharma company belong to?
The ESSA Pharma sector is Healthcare.
ESSA Pharma EPIX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}